Boston Trust Walden Corp Becton Dickinson & CO Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Boston Trust Walden Corp holds 355,955 shares of BDX stock, worth $80.8 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

355,955

Previous 381,448 6.68%

Holding current value

$80.8 Million

Previous $89.1 Million 3.73%

% of portfolio

0.61%

Previous 0.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$221.47 - $242.41 $5.65 Million - $6.18 Million	-25,493 Reduced 6.68%	355,955 $85.8 Million
Q2 2024 Jul 19, 2024	SELL	$225.07 - $246.17 $4.44 Million - $4.85 Million	-19,708 Reduced 4.91%	381,448 $89.1 Million
Q1 2024 Apr 22, 2024	BUY	$233.45 - $247.73 $772,252 - $819,490	3,308 Added 0.83%	401,156 $99.3 Million
Q4 2023 Jan 24, 2024	SELL	$232.24 - $267.23 $155,600 - $179,044	-670 Reduced 0.17%	397,848 $97 Million
Q3 2023 Oct 18, 2023	SELL	$254.9 - $283.59 $1.21 Million - $1.35 Million	-4,766 Reduced 1.18%	398,518 $103 Million
Q2 2023 Jul 24, 2023	SELL	$238.39 - $265.32 $664,154 - $739,181	-2,786 Reduced 0.69%	403,284 $106 Million
Q1 2023 Apr 19, 2023	SELL	$229.71 - $259.35 $7.91 Million - $8.94 Million	-34,456 Reduced 7.82%	406,070 $101 Million
Q4 2022 Jan 20, 2023	BUY	$218.29 - $256.91 $2.49 Million - $2.93 Million	11,403 Added 2.66%	440,526 $0
Q3 2022 Oct 19, 2022	SELL	$51.03 - $264.23 $695,283 - $3.6 Million	-13,625 Reduced 3.08%	429,123 $95.6 Million
Q2 2022 Jul 22, 2022	BUY	$234.74 - $275.42 $720,417 - $845,263	3,069 Added 0.7%	442,748 $109 Million
Q1 2022 Apr 20, 2022	BUY	$243.64 - $270.48 $739,934 - $821,447	3,037 Added 0.7%	439,679 $117 Million
Q4 2021 Jan 21, 2022	BUY	$230.08 - $250.94 $2.34 Million - $2.56 Million	10,188 Added 2.39%	436,642 $110 Million
Q3 2021 Oct 25, 2021	BUY	$232.72 - $256.47 $10.6 Million - $11.7 Million	45,638 Added 11.98%	426,454 $105 Million
Q2 2021 Jul 22, 2021	SELL	$232.65 - $254.58 $57,231 - $62,626	-246 Reduced 0.06%	380,816 $92.6 Million
Q1 2021 Apr 21, 2021	SELL	$232.09 - $256.88 $400,123 - $442,861	-1,724 Reduced 0.45%	381,062 $92.7 Million
Q4 2020 Jan 15, 2021	SELL	$221.92 - $245.94 $131,598 - $145,842	-593 Reduced 0.15%	382,786 $95.8 Million
Q3 2020 Oct 14, 2020	SELL	$215.77 - $276.76 $485,914 - $623,263	-2,252 Reduced 0.58%	383,379 $89.2 Million
Q2 2020 Jul 23, 2020	SELL	$219.9 - $263.41 $2.51 Million - $3.01 Million	-11,420 Reduced 2.88%	385,631 $92.3 Million
Q1 2020 Apr 21, 2020	SELL	$195.69 - $279.01 $14.5 Million - $20.7 Million	-74,153 Reduced 15.74%	397,051 $91.2 Million
Q4 2019 Jan 10, 2020	SELL	$236.45 - $266.82 $853,111 - $962,686	-3,608 Reduced 0.76%	471,204 $128 Million
Q3 2019 Oct 21, 2019	SELL	$230.58 - $256.08 $933,618 - $1.04 Million	-4,049 Reduced 0.85%	474,812 $120 Million
Q2 2019 Jul 25, 2019	SELL	$217.4 - $246.08 $538,065 - $609,048	-2,475 Reduced 0.51%	478,861 $121 Million
Q1 2019 Apr 16, 2019	BUY	$206.05 - $248.17 $2.34 Million - $2.81 Million	11,342 Added 2.41%	481,336 $120 Million
Q4 2018 Jan 17, 2019	SELL	$204.73 - $257.93 $3.32 Million - $4.19 Million	-16,239 Reduced 3.34%	469,994 $106 Million
Q3 2018 Oct 23, 2018	SELL	$233.07 - $256.0 $643,273 - $706,560	-2,760 Reduced 0.56%	486,233 $127 Million
Q2 2018 Jul 25, 2018	SELL	$208.1 - $233.85 $560,205 - $629,524	-2,692 Reduced 0.55%	488,993 $117 Million
Q1 2018 Apr 13, 2018	SELL	$205.46 - $240.27 $6.67 Million - $7.8 Million	-32,462 Reduced 6.19%	491,685 $107 Million
Q4 2017 Jan 29, 2018	BUY	$189.0 - $222.64 $13 Million - $15.3 Million	68,759 Added 15.1%	524,147 $112 Million
Q3 2017 Oct 13, 2017	BUY	$186.89 - $198.9 $85.1 Million - $90.6 Million	455,388	455,388 $89.2 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Becton Dickinson & CO Transaction History